Hepatic neddylation targets and stabilizes electron transfer flavoproteins to facilitate fatty acid β-oxidation

• Published in: Proceedings of the National Academy of Sciences - PNAS 2020-02, Vol.117 (5), p.2473-2483
• Main Authors: Zhang, Xueying, Zhang, Yao-Lin, Qiu, Guihua, Pian, Lili, Guo, Lu, Cao, Huanling, Liu, Jian, Zhao, Yawei, Li, Xin, Xu, Zhe, Huang, Xiaofeng, Huang, Jingru, Dong, Jie, Shen, Beifen, Wang, Hong-Xia, Ying, Xiaomin, Zhang, Weiping J., Cao, Xuetao, Zhang, Jiyan
• Format: Article
• Language: English
• Subjects: Abnormalities; Aciduria; Animal models; Biological Sciences; Cell survival; Electron transfer; Embryos; Enzymes; Fatty acids; Fatty liver; Flavoproteins; Hepatocytes; Liver; Metabolism; Mitochondria; Mutation; Neonates; Oxidation; Proteins; Senescence; Steatosis; Substrate inhibition; Substrates; Target recognition; Ubiquinone; Ubiquinone oxidoreductase; Ubiquitin; Ubiquitination
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.1910765117

Neddylation is a ubiquitination-like pathway that controls cell survival and proliferation by covalently conjugating NEDD8 to lysines in specific substrate proteins. However, the physiological role of neddylation in mammalian metabolism remains elusive, and no mitochondrial targets have been identified. Here, we report that mouse models with liver-specific deficiency of NEDD8 or ubiquitin-like modifier activating enzyme 3 (UBA3), the catalytic subunit of the NEDD8-activating enzyme, exhibit neonatal death with spontaneous fatty liver as well as hepatic cellular senescence. In particular, liver-specific UBA3 deficiency leads to systemic abnormalities similar to glutaric aciduria type II (GA-II), a rare autosomal recessive inherited fatty acid oxidation disorder resulting from defects in mitochondrial electron transfer flavoproteins (ETFs: ETFA and ETFB) or the corresponding ubiquinone oxidoreductase. Neddylation inhibition by various strategies results in decreased protein levels of ETFs in neonatal livers and embryonic hepatocytes. Hepatic neddylation also enhances ETF expression in adult mice and prevents fasting-induced steatosis and mortality. Interestingly, neddylation is active in hepatic mitochondria. ETFs are neddylation substrates, and neddylation stabilizes ETFs by inhibiting their ubiquitination and degradation. Moreover, certain mutations of ETFs found in GA-II patients hinder the neddylation of these substrates. Taken together, our results reveal substrates for neddylation and add insight into GA-II.